Bio-Rad Laboratories, Inc. (BIO) Misses Q1 EPS by 16c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $356.26 -1.36%
Financial Fact:
Net income including noncontrolling interests: 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Net income including noncontrolling interests: 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Bio-Rad Laboratories, Inc. (NYSE: BIO) reported Q1 EPS of $1.16, $0.16 worse than the analyst estimate of $1.32. Revenue for the quarter came in at $485.1 million versus the consensus estimate of $482.11 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
